Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.36% | 35.54% | 46.11% | 184.33% | 454.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.36% | 35.54% | 46.11% | 184.33% | 454.39% |
| Cost of Revenue | 21.18% | 27.18% | 34.42% | 147.08% | 322.45% |
| Gross Profit | 87.67% | 152.61% | 400.99% | 954.41% | 371.34% |
| SG&A Expenses | -18.14% | -11.20% | -3.98% | 46.09% | 63.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 45.61% | 45.59% | 25.07% | -124.50% | -120.85% |
| Total Operating Expenses | 15.65% | 20.55% | 26.07% | 88.94% | 106.54% |
| Operating Income | 121.34% | 78.62% | 58.39% | 65.07% | 75.23% |
| Income Before Tax | -79.14% | -79.45% | -79.75% | 36.75% | 647.49% |
| Income Tax Expenses | -108.47% | 10.07% | 42.68% | 68.21% | 77.00% |
| Earnings from Continuing Operations | -78.54% | -78.95% | -79.34% | 33.19% | 722.25% |
| Earnings from Discontinued Operations | -- | -- | -- | 31.52% | 938.64% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -146.76% | -146.88% |
| Net Income | -81.22% | -81.46% | -81.69% | 40.43% | 671.41% |
| EBIT | 121.34% | 78.62% | 58.39% | 65.07% | 75.23% |
| EBITDA | 58.70% | 296.06% | 279.97% | 173.82% | 132.34% |
| EPS Basic | -81.31% | -81.50% | -81.68% | 40.24% | 671.15% |
| Normalized Basic EPS | 55.81% | 58.82% | 61.02% | 36.54% | 16.50% |
| EPS Diluted | -97.62% | -98.07% | -98.50% | 58.02% | 342.31% |
| Normalized Diluted EPS | 65.38% | 67.65% | 69.05% | 55.17% | 49.51% |
| Average Basic Shares Outstanding | 0.24% | 0.24% | 0.24% | 0.12% | 0.00% |
| Average Diluted Shares Outstanding | 86.05% | 86.05% | 86.05% | 75.21% | 58.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |